EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nitazoxanide Inhibits the Bifunctional Enzyme GlG6PD::6PGL of Giardia lamblia: Biochemical and In Silico Characterization of a New Druggable Target

Víctor Martínez-Rosas iD, Beatriz Hernández-Ochoa, Laura Morales-Luna, Daniel Ortega-Cuellar iD, Abigail González-Valdez, Roberto Arreguin-Espinosa iD, Yadira Rufino-González iD, Ernesto Calderón-Jaimes, Rosa Angélica Castillo-Rodríguez iD, Carlos Wong-Baeza iD, Isabel Baeza-Ramírez, Verónica Pérez de la Cruz iD und 2 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241411516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Víctor Martínez-Rosas und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Bioquímica Genética, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City 04530, Mexico. Hauptthemen laut MEDLINE: Giardia lamblia, Giardiasis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: E022 Program, National Institute of Pediatrics, Mexico City, Mexico (Recursos Fiscales para la Investigación), Recursos Federales, National Supercomputing Center-IPICYT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Giardiasis, which is caused by Giardia lamblia infection, is a relevant cause of morbidity and mortality worldwide. Because no vaccines are currently available to treat giardiasis, chemotherapeutic drugs are the main options for controlling infection. Evidence has shown that the nitro drug nitazoxanide (NTZ) is a commonly prescribed treatment for giardiasis; however, the mechanisms underlying NTZ’s antigiardial activity are not well-understood. Herein, we identified the glucose-6-phosphate::6-phosphogluconate dehydrogenase (GlG6PD::6PGL) fused enzyme as a nitazoxanide target, as NTZ behaves as a GlG6PD::6PGL catalytic inhibitor. Furthermore, fluorescence assays suggest alterations in the stability of GlG6PD::6PGL protein, whereas the results indicate a loss of catalytic activity due to conformational and folding changes. Molecular docking and dynamic simulation studies suggest a model of NTZ binding on the active site of the G6PD domain and near the structural NADP+ binding site. The findings of this study provide a novel mechanistic basis and strategy for the antigiardial activity of the NTZ drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Giardia lambliaGiardiasisHumansMolecular Docking SimulationThiazolesNitro Compounds

Stichwörter der Autor:innen

G6PD::6PGLinhibitionmolecular dynamics simulationspolypharmacology

Substanzen

ThiazolesnitazoxanideNitro Compounds

Autor:innen und Institutionen

  • Laboratorio de Bioquímica Genética, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City 04530, Mexico.
  • Programa de Posgrado en Biomedicina y Biotecnología Molecular, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
  • Laboratorio de Inmunoquímica, Hospital Infantil de México Federico Gómez, Secretaría de Salud, Mexico City 06720, Mexico.
  • Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
  • Laboratorio de Nutrición Experimental, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City 04530, Mexico.
  • Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.

ORCID-Profile: Víctor Martínez-Rosas, Daniel Ortega-Cuellar, Roberto Arreguin-Espinosa, Yadira Rufino-González, Rosa Angélica Castillo-Rodríguez, Carlos Wong-Baeza, Verónica Pérez de la Cruz, Abraham Vidal-Limón, Saúl Gómez-Manzo

Förderung

  • E022 Program, National Institute of Pediatrics, Mexico City, Mexico (Recursos Fiscales para la Investigación)
  • Recursos Federales
  • National Supercomputing Center-IPICYT
  • INP 021/2022
  • HIM/2019/036 SSA. 1595
  • National Supercomputing Center–IPICYT for the computational resources

Zitieren

APA

Martínez-Rosas, V., Hernández-Ochoa, B., Morales-Luna, L., Ortega-Cuellar, D., González-Valdez, A., Arreguin-Espinosa, R., Rufino-González, Y., Calderón-Jaimes, E., Castillo-Rodríguez, R. A., Wong-Baeza, C., Baeza-Ramírez, I., Pérez de la Cruz, V., Vidal-Limón, A., & Gómez-Manzo, S. (2023). Nitazoxanide Inhibits the Bifunctional Enzyme GlG6PD::6PGL of Giardia lamblia: Biochemical and In Silico Characterization of a New Druggable Target. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411516

Vancouver

Martínez-Rosas V, Hernández-Ochoa B, Morales-Luna L, Ortega-Cuellar D, González-Valdez A, Arreguin-Espinosa R, et al. Nitazoxanide Inhibits the Bifunctional Enzyme GlG6PD::6PGL of Giardia lamblia: Biochemical and In Silico Characterization of a New Druggable Target. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411516

BibTeX
@article{MartnezRosas2023,
  author = {Martínez-Rosas, Víctor and Hernández-Ochoa, Beatriz and Morales-Luna, Laura and Ortega-Cuellar, Daniel and González-Valdez, Abigail and Arreguin-Espinosa, Roberto and Rufino-González, Yadira and Calderón-Jaimes, Ernesto and Castillo-Rodríguez, Rosa Angélica and Wong-Baeza, Carlos and Baeza-Ramírez, Isabel and Pérez de la Cruz, Verónica and Vidal-Limón, Abraham and Gómez-Manzo, Saúl},
  title = {Nitazoxanide Inhibits the Bifunctional Enzyme GlG6PD::6PGL of Giardia lamblia: Biochemical and In Silico Characterization of a New Druggable Target},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241411516}
}
Kostenlos starten →